ライフサイエンスコーパス: gastroschisis

1 reatments for Hirschsprung's Disease(HD) and gastroschisis.

2 phageal atresia, and ruptured omphalocele or gastroschisis.

3 we examined the association between GUI and gastroschisis.

4 evidence that UTIs may increase the risk of gastroschisis.

5 PAHs among mothers who are >/= 20 years and gastroschisis.

6 e of asthma antiinflammatory medications and gastroschisis.

7 the periconceptional period and the risk of gastroschisis.

8 r 1997, the authors treated 80 children with gastroschisis.

9 re has been a decrease in primary closure of gastroschisis.

10 en 1993 and 1997, 38 children presented with gastroschisis.

11 rin use in early pregnancy increases risk of gastroschisis.

12 identified, with 10 527 infant diagnoses of gastroschisis.

13 ine were associated with infant diagnoses of gastroschisis.

14 to determine how best to treat infants with gastroschisis.

15 use estimates were higher among infants with gastroschisis.

16 ) were associated with a higher incidence of gastroschisis (1 year: adjusted odds ratio [AOR], 1.12 [

17 Delayed children with gastroschisis (1.48; 1.25, 1.75) and esophageal atresia

18 -5.26]), hypospadias (1.96 [0.98-3.92]), and gastroschisis (3.19 [0.95-10.77]).

19 ophageal fistula (66% to 87%, P < 0.001) and gastroschisis (76% to 89%, P < 0.001).

20 thout cleft palate (14%), omphalocele (60%), gastroschisis (76%), Down syndrome (43%), trisomy 18 (61

21 omplicated appendicitis (14.1% [$51702402]), gastroschisis (9.5% [$34940331]), gastrostomy (5.8% [$21

22 The incidence of gastroschisis, a birth defect involving the herniation o

23 t this hypothesis, we examined neonates with gastroschisis, a congenital abdominal wall defect that l

24 e enriched in the cord blood of infants with gastroschisis, a natural model of chronic inflammation o

25 ity of ACLP(-/-) mice die perinatally due to gastroschisis, a severe disruption of the anterior abdom

26 n elevated statistically significant risk of gastroschisis (adjusted odds ratio = 2.06, 95% confidenc

27 ween estimated occupational PAH exposure and gastroschisis among children whose mothers were employed

28 nt association between occupational PAHs and gastroschisis among mothers >/= 20 years of age [odds ra

29 e-control study of mothers of offspring with gastroschisis and age-matched controls.

30 er 30-day ACM risk and delayed children with gastroschisis and esophageal atresia had greater 30-day

31 inhaled beta2-agonists for cleft palate and gastroschisis and found a potential new signal for renal

32 life events and social support with risks of gastroschisis and hypospadias, using data from the Natio

33 population before transplant were intestinal gastroschisis and intestinal dysmotility syndromes in ch

34 A 2-year-old boy born with gastroschisis and intestinal malrotation lost his entire

35 al drug use is a significant risk factor for gastroschisis and is one of a constellation of potential

36 Abdominal wall defects comprising both gastroschisis and omphalocele remain a source of signifi

37 binations, increased risks were observed for gastroschisis and other specific brain anomalies after a

38 causes of intestinal and liver failure were gastroschisis and parenteral nutrition.

39 ough/cold/analgesic medications and risks of gastroschisis and SIA.

40 Gastroschisis and small intestinal atresia (SIA) are bir

41 Gastroschisis and small-intestinal atresia may be partic

42 y factors associated with the development of gastroschisis and to evaluate the mode, timing, and loca

43 en a number of new prenatal interventions in gastroschisis, and a better understanding of gestational

44 esia, biliary atresia, diaphragmatic hernia, gastroschisis, and Down syndrome with an associated CHD

45 testinal atresia, necrotizing enterocolitis, gastroschisis, and midgut volvulus.

46 s of oral clefts associated with olanzapine, gastroschisis, and other specific brain anomalies with a

47 The cases included 381 infants with isolated gastroschisis, and the controls were 4,121 liveborn infa

48 rimary EBV infection was not associated with gastroschisis, but observed associations with both IgM a

49 lable, the effects of disease on the risk of gastroschisis cannot be ruled out.

50 From 1998 to 2010, mothers of 249 gastroschisis cases and 7,104 controls were interviewed

51 Data from gastroschisis cases and control infants were obtained fr

52 periconceptional period among mothers of 593 gastroschisis cases, 1,142 male hypospadias cases, and 4

53 From 1995 to 1999, the mothers of 206 gastroschisis cases, 126 SIA cases, and 798 controls in

54 During the study period, the rate of gastroschisis decreased from 0.31 (95% CI, 0.29-0.33) to

55 The adjusted odds ratios for gastroschisis for a 4-point increase in the stress index

56 tion of the association between atrazine and gastroschisis has been limited.

57 inal wall defects (primarily omphalocele and gastroschisis) has improved, but controversy remains reg

58 Outcomes for infants with gastroschisis have paralleled advances made in neonatal

59 Previous studies of gastroschisis have suggested that risk is increased for

60 esticide atrazine is a hypothesized cause of gastroschisis; however, examination of the association b

61 duction defects, anorectal atresia/stenosis, gastroschisis, hydrocephalus, other specific brain anoma

62 have been associated with increased risk of gastroschisis in 2 studies.

63 d maternal occupational exposure to PAHs and gastroschisis in offspring.

64 to PAHs during pregnancy is associated with gastroschisis in offspring; however, to our knowledge, n

65 r primary treatment of HD in review one, and gastroschisis in review two.

66 The primary outcome was gastroschisis incidence.

67 the hypothesis that the birth prevalence of gastroschisis is positively associated with use of recre

68 partment syndrome has made staged closure of gastroschisis more common in the authors' practice.

69 l age is the strongest known risk factor for gastroschisis, most cases are born to mothers >/= 20 yea

70 the most common cause in the PG followed by gastroschisis (n=5), intestinal atresia (n=5), and necro

71 = 3,877], diaphragmatic hernia [n = 6,176], gastroschisis [n = 4,845], Down syndrome by presence of

72 ositive) and anophthalmia/microphthalmia and gastroschisis (negative).

73 non-delayed children, delayed children with gastroschisis, omphalocele, intestinal atresia, and esop

74 eft palate (OR, 1.63; 95% CI, 1.05-2.52) and gastroschisis (OR, 1.89; 95% CI, 1.12-3.20) had signific

75 In infants with gastroschisis, outcomes were compared between those wher

76 respectively (p < 0.001 for all, except for gastroschisis [p = 0.029]).

77 utcomes are currently investigated in HD and gastroschisis research so as to counter this heterogenei

78 icant risk of reporting bias exist in HD and gastroschisis research.

79 Gastroschisis risk is highest in offspring of young wome

80 edrine has previously been shown to increase gastroschisis risk, findings of this study raise questio

81 tomegalovirus IgG did not appear to increase gastroschisis risk.

82 non-delayed children, delayed children with gastroschisis (RR: 1.62; 1.07, 2.47), omphalocele (RR: 1

83 We determined that patients with gastroschisis show high systemic levels of inflammatory

84 Thirty gastroschisis studies were eligible for inclusion in the

85 Using a mouse model of gastroschisis, we observed higher numbers of eosinophils

86 tically significant adjusted odds ratios for gastroschisis were associated with first-trimester use o

87 Conditions such as acrania, exomphalos, and gastroschisis were commonly detected early regardless of

88 Risks of gastroschisis were elevated for use of aspirin (odds rat

89 Infants with gastroschisis were more likely to have mothers who ident

90 Most were Latino children with gastroschisis who received multivisceral grafts.

91 ation at the hospital level was greatest for gastroschisis (WIQR, $48471; median, $111566 [IQR, $9119